Sociedad Americana de Hirudoterapia

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study

Michalsen A, Moebus S, Spahn G, Esch T, Langhorst J, Dobos GJ (2002) · Alternative Therapies in Health and Medicine · n=16

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Knee Osteoarthritis
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Michalsen A 200216
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center, observational, controlled, non-randomized pilot study (Essen, Germany)
Sample size (n)
16
Intervention
Single trial of 4 Hirudo medicinalis leeches applied topically at painful periarticular sites of the knee joint
Comparator
Conventional inpatient pain treatment excluding NSAIDs (n=6 control inpatients)
Primary endpoint
Self-reported general knee pain on visual analog scale, daily for 10 days and follow-up at day 28
Primary result
Periarticular application of 4 leeches produced rapid pain relief with sustained improvement at 4 weeks; no major complications observed (descriptive analysis given small n)
Follow-up duration
28 days

Key Findings

  • First modern controlled pilot study of leech therapy in knee OA — predecessor to the landmark Michalsen 2003 RCT
  • Established the protocol of single-session 4-leech periarticular application later used across the Essen program
  • Pain reduction onset within days of single session in 10 leech-treated inpatients
  • No serious adverse events; treatment well tolerated in elderly OA inpatients (mean age 69 years)
  • Provided the proof-of-concept and effect-size estimate that powered the 2003 RCT

Limitations

  • Non-randomized, observational design — high risk of selection bias
  • Very small sample (n=16; 10 leech vs 6 control)
  • Open-label inpatient setting — strong attention and expectancy effects
  • No biomarker or imaging endpoints
  • Single center (Kliniken Essen-Mitte) — same group that ran subsequent RCTs

Clinical Implications

Michalsen 2002 is the foundational pilot study of the modern hirudotherapy evidence base. It established the periarticular 4-leech single-session protocol that became standard in subsequent German trials. Methodologically it is a controlled but non-randomized pilot; clinicians should cite it as historical context rather than as evidence of efficacy. Its principal value is documenting the safety and feasibility signal that motivated the funding and design of Michalsen 2003 — and through that, the entire subsequent line of European RCTs.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.